Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson Disease Psychosis”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Early research (Phase 1)Not Yet RecruitingNCT06793995
What this trial is testing

Effect of Food and Age on the Pharmacokinetics of LY03017

Who this might be right for
Alzheimer's Disease PsychosisParkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 26
Not applicableUnknownNCT04399096
What this trial is testing

Sound and Vision: A Collaboration Between Service-users, Artists and the Public to Explore the Lived Experience of Hallucinations

Who this might be right for
SchizophreniaParkinson DiseaseHallucinations
University of Cambridge 500
Large-scale testing (Phase 3)Study completedNCT00477672
What this trial is testing

The Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 298
Large-scale testing (Phase 3)Study completedNCT00658567
What this trial is testing

Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 123
Post-approval studies (Phase 4)Looking for participantsNCT05590637
What this trial is testing

Comparing Antipsychotic Medications in LBD Over Time

Who this might be right for
Parkinson's Disease PsychosisDementia With Lewy Bodies
The University of Texas Health Science Center at San Antonio 94
Post-approval studies (Phase 4)Study completedNCT00043849
What this trial is testing

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

Who this might be right for
DementiaParkinson Disease
National Institute on Aging (NIA) 60
Testing effectiveness (Phase 2)WithdrawnNCT05344365
What this trial is testing

Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
Vanda Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT00095810
What this trial is testing

Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

Who this might be right for
Parkinson's DiseasePsychoses
Otsuka Pharmaceutical Development & Commercialization, Inc. 50
Not applicableUnknownNCT04592965
What this trial is testing

Hallucinations in Parkinson's Disease

Who this might be right for
Parkinson Disease Psychosis
Olaf Blanke 40
Early research (Phase 1)Looking for participantsNCT05995782
What this trial is testing

A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418

Who this might be right for
Parkinson Disease PsychosisAmyotrophic Lateral Sclerosis (ALS)
1ST Biotherapeutics, Inc. 64
Testing effectiveness (Phase 2)Study completedNCT02969369
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 39
Not applicableApproved For MarketingNCT02762591
What this trial is testing

Expanded Access of Pimavanserin for Patients With PD Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc.
Post-approval studies (Phase 4)Looking for participantsNCT06634641
What this trial is testing

Clozapine-related Immunodeficiency in Parkinsons Disease

Who this might be right for
ClozapineParkinson's Disease (PD)Immunodeficiency+1 more
Centre Hospitalier Universitaire, Amiens 24
Large-scale testing (Phase 3)Study completedNCT03325556
What this trial is testing

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Who this might be right for
Dementia-related Psychosis
ACADIA Pharmaceuticals Inc. 392
Not applicableUnknownNCT04579887
What this trial is testing

Presence Hallucination in Parkinson's Disease

Who this might be right for
Parkinson Disease Psychosis
Olaf Blanke 10
Not applicableStudy completedNCT00360633
What this trial is testing

Psychiatric and Cognitive Manifestations of Parkinson's Disease

Who this might be right for
Parkinson's Disease
NYU Langone Health 36
Post-approval studies (Phase 4)Study completedNCT04292223
What this trial is testing

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
ACADIA Pharmaceuticals Inc. 29
Not applicableStudy completedNCT00024622
What this trial is testing

PET Scanning in Parkinson s Disease

Who this might be right for
SchizophreniaParkinson's Disease
National Institute of Mental Health (NIMH) 502
Not applicableLooking for participantsNCT07509125
What this trial is testing

Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders

Who this might be right for
Alzheimer Dementia (AD)ALS - Amyotrophic Lateral SclerosisParkinson s Disease+7 more
Universitaire Ziekenhuizen KU Leuven 300
Testing effectiveness (Phase 2)Study completedNCT00087542
What this trial is testing

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

Who this might be right for
HallucinationsPsychosesParkinson's Disease
ACADIA Pharmaceuticals Inc. 60
Load More Results